Live Survival updates

Live Survival news coverage of developments with the latest updates. Stay on top of latest Survival news stories and find out what just happened, what is going on with Survival. The latest real-time news updates and headlines on Survival
Closing Australia's Knowledge Gap Of Its Dispossession History
Exercise Tied to Longer Cancer Survival, Disease-Free Time
Pre-European Indigenous Population Larger Than Believed
NEC Inflammation Links Gut to Neurodevelopmental Issues
Lismore Residents Urged: Take Bus in Emergency Drill
Silent Aneurysms Trigger Long-Term Anxiety
New Plan Targets Healthier Market for Child Cancer Drugs
Research Illuminates Dementia in Indigenous Bolivians
Exotic Trees in Cities Attract Giant Resin Bee
Research Reveals 2M Indigenous Lived in Australia in 1788
Indigenous Australian Population Larger, Decimated Post-Fleet
Commissioners Slam Senator Hanson for Racist Remarks
Unthinkable to Inevitable: Overton Window Theory
Class II/III BRAF Alterations in NSCLC: Unique Outcomes
New Immunotherapy Doubles Survival in Advanced NSCLC
Early Brain Radiation Benefits EGFR-mutant NSCLC Patients
IASLC Tumor Budding Grade Flags High-Risk Lung Cancer
Georgetown Reveals PAPILLON Trial: Long-Term Lung Cancer Survival
MRI Brain Watch Beats Cranial Radiation in Lung Cancer
NASA Taps New Crops, Health Research for Exploration
DUDE 44 Bravo: Warrior Ethos in Action
Hormone Pollution Turns Male Fish Fiercer, Poorer Dads
Cryopreserved Sperm to Safeguard Endangered Pupfish
New Method Tested Against Bacterial Toxin In Brain
Metabolic Weakness Linked to Heart Development
UWA Tall Poppies Scoop New National Awards
Griffith Welcomes New CPR And AED Equipment
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
Amivantamab-Chemo Yields Best Survival in EGFR NSCLC
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Trastuzumab Deruxtecan Boosts Survival in HER2 Lung Cancer
Cancer Survival Up, But Legal and Financial Costs Rise
MAVERICK Trial Backs Brain MRI Alone for Lung Cancer
Phase III TAISHAN-302: Tam-Peli Boosts Survival in SCLC
ARTEMIS-008: Risvutatug Boosts Survival in Lung Cancer
Ivonescimab Boosts Survival in PD-L1+ Advanced NSCLC
Sacituzumab, Pembrolizumab Combo Misses NSCLC Targets
Tarlatamab Dosing Shows Promise in Small Cell Lung Cancer
Therapy Fails to Boost Survival After Dual Immunotherapy
Phase 1 Backs Phase 3 Dose for Lung Cancer Drug
Atezolizumab Combo Doubles Event-Free Survival in NSCLC
Bushfires Alert: Watch & Act on Girraween Road
SERENA-4 Trial: Etcamah, Palbociclib in ER+ Breast Cancer
UNC Unveils Tool to Identify High-Risk Cancer Periods
Antiviral Defense Clash Sheds Light on Lupus Genetics
Lincoln Lab Device Wins 2026 Tech Transfer Award
90th Fighter Squadron Captain Wins 2025 Kolligian Trophy